A 1-year per-patient cost of therapy administration analysis of mosunetuzumab and tisagenlecleucel in relapsed or refractory follicular lymphoma patients receiving two or more lines of systemic therapy
Objective: A per-patient cost of therapy administration model was developed to estimate the cost of mosunetuzumab vs. tisagenlecleucel in patients with relapsing or refractory follicular lymphoma (R/R FL) receiving two or more lines of systemic therapy (3L+) from both the Italian hospital and societ...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AboutScience Srl
2024-12-01
|
| Serier: | Global & Regional Health Technology Assessment |
| Fag: | |
| Online adgang: | https://journals.aboutscience.eu/index.php/grhta/article/view/3170 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|